Ustekinumab for the treatment of moderate to severe psoriasis

Gospodarevskaya E, Picot J, Cooper K, Loveman E, Takeda A
Record ID 32013000638
English
Details
Project Status: Completed
Year Published: 2009
URL for additional information: http://www.hta.ac.uk/1819
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Adult
  • Antibodies, Monoclonal, Humanized
  • Cost-Benefit Analysis
  • Randomized Controlled Trials as Topic
  • Ustekinumab
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Psoriasis
Contact
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: 2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.